Cargando…

Clinical significance of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD): potential target for prevention of airway fibrosis and lung cancer

Unfortunately, the research effort directed into chronic obstructive pulmonary disease (COPD) has been disproportionately weak compared to its social importance, and indeed it is the least researched of all common chronic conditions. Tobacco smoking is the major etiological factor. Only 25% of smoke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sohal, Sukhwinder Singh, Mahmood, Malik Quasir, Walters, Eugene Haydn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607924/ https://www.ncbi.nlm.nih.gov/pubmed/26932377 http://dx.doi.org/10.1186/s40169-014-0033-2

Ejemplares similares

Epithelial mesenchymal transition (EMT) in small airways of COPD patients
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2013)

Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD)
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2013)

β-catenin, Twist and Snail: Transcriptional regulation of EMT in smokers and COPD, and relation to airflow obstruction
por: Mahmood, Malik Quasir, et al.
Publicado: (2017)

Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction
por: Mahmood, Malik Quasir, et al.
Publicado: (2015)

Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease
por: Shukla, Shakti Dhar, et al.
Publicado: (2014)

Essential need for rethink of COPD airway pathology: implications for new drug approaches for prevention of lung cancer as well as small airway fibrosis
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2017)

A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial–mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2014)

The Underappreciated Role of Epithelial Mesenchymal Transition in Chronic Obstructive Pulmonary Disease and Its Strong Link to Lung Cancer
por: Mahmood, Malik Quasir, et al.
Publicado: (2021)

Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer: Epithelial Mesenchymal Transition (EMT), the Missing Link?
por: Sohal, Sukhwinder Singh
Publicado: (2015)

Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial–mesenchymal transition
por: Eapen, Mathew Suji, et al.
Publicado: (2021)

Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease
por: Sohal, Sukhwinder S, et al.
Publicado: (2011)

The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL)
por: Shukla, Shakti Dhar, et al.
Publicado: (2017)

WNT/β-catenin pathway: A novel therapeutic target for attenuating airway remodelling and EMT in COPD
por: Eapen, Mathew Suji, et al.
Publicado: (2020)

Endothelial to mesenchymal transition (EndMT): an active process in Chronic Obstructive Pulmonary Disease (COPD)?
por: Sohal, Sukhwinder Singh
Publicado: (2016)

Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
por: Soltani, Amir, et al.
Publicado: (2016)

Changes in Airway Histone Deacetylase2 in Smokers and COPD with Inhaled Corticosteroids: A Randomized Controlled Trial
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2013)

Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease
por: Soltani, Amir, et al.
Publicado: (2012)

Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD)
por: Eapen, Mathew Suji, et al.
Publicado: (2017)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Epithelial–mesenchymal transition is driven by transcriptional and post transcriptional modulations in COPD: implications for disease progression and new therapeutics
por: Eapen, Mathew Suji, et al.
Publicado: (2019)

Reticular Basement Membrane Vessels Are Increased in COPD Bronchial Mucosa by Both Factor VIII and Collagen IV Immunostaining and Are Hyperpermeable
por: Soltani, Amir, et al.
Publicado: (2012)

Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing, Tissue Regeneration and Organ Fibrosis
por: Marconi, Guya D., et al.
Publicado: (2021)

Vessel-Associated Transforming Growth Factor-Beta1 (TGF-β1) Is Increased in the Bronchial Reticular Basement Membrane in COPD and Normal Smokers
por: Soltani, Amir, et al.
Publicado: (2012)

Transforming growth factor-β1 and SMAD signalling pathway in the small airways of smokers and patients with COPD: potential role in driving fibrotic type-2 epithelial mesenchymal transition
por: Brake, Samuel James, et al.
Publicado: (2023)

Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis
por: Tennakoon, Anusha H., et al.
Publicado: (2015)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study
por: Soltani, Amir, et al.
Publicado: (2010)

Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
por: Sohal, Sukhwinder Singh
Publicado: (2017)

Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT)
por: Kang, Hyunkoo, et al.
Publicado: (2019)

The Epithelial-to-Mesenchymal Transition (EMT), a Particular Case
por: Cebrià-Costa, Joan Pau, et al.
Publicado: (2014)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases
por: Sarrand, Julie, et al.
Publicado: (2023)

Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells
por: Llorián-Salvador, María, et al.
Publicado: (2022)

Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology
por: Rout-Pitt, Nathan, et al.
Publicado: (2018)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Therapeutic Modalities for Asthma, COPD, and Pathogenesis of COVID-19: Insights from the Special Issue
por: Sohal, Sukhwinder Singh
Publicado: (2022)

Endogenous Anti-Cancer Candidates in GPCR, ER Stress, and EMT
por: Gundamaraju, Rohit, et al.
Publicado: (2020)

Fully integrating pathophysiological insights in COPD: an updated working disease model to broaden therapeutic vision
por: Walters, E. Haydn, et al.
Publicado: (2021)

Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
por: Zvaifler, Nathan J
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_jvfclhpd66mpuc9pkm82e200t1